HROW FY 2021 Earnings — Harrow Health, Inc. Revenue & Financial Results | Market Cap Arena

HROWHarrow Health, Inc.

$1B

FY 2021 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$72M+48.3% YoY

Gross Profit

$54M74.9% margin

Operating Income

$2M2.2% margin

Net Income

-$18M-24.8% margin

EPS (Diluted)

$-0.69

Cash Flow

Operating Cash Flow

$5M

Free Cash Flow

-$23M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$98M

Total Liabilities

$87M

Stockholders' Equity

$11M

Cash & Equivalents

$42M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$72M	$49M	+48.3%
Gross Profit	$54M	$34M	+57.7%
Operating Income	$2M	$385,000	+319.2%
Net Income	-$18M	-$3M	-436.4%